Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).

ABSTRACT:

Unlabelled

Age-related macular degeneration (AMD) is still referred to as the leading cause of severe and irreversible visual loss world-wide. The disease has a profound effect on quality of life of affected individuals and represents a major socioeconomic challenge for societies due to the exponential increase in life expectancy and environmental risks. Advances in medical research have identified vascular endothelial growth factor (VEGF) as an important pathophysiological player in neovascular AMD and intraocular inhibition of VEGF as one of the most efficient therapies in medicine. The wide introduction of anti-VEGF therapy has led to an overwhelming improvement in the prognosis of patients affected by neovascular AMD, allowing recovery and maintenance of visual function in the

SUBMITTER: Schmidt-Erfurth U 

PROVIDER: S-EPMC4145443 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature